🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to message these profiles privately for source information, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and claims of rapid British shipping. Vendors market the drug there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in users administering products of unknown origin.

Several experts said the popularity for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, advertising, and consumer laws, potentially leading to fines, legal action or prison.

Service Response and Content Removal

Based on the social media company, the service has removed violative content and banned related hashtags and search suggestions. The company said it was committed to keeping the service safe and investing in enhancing enforcement strategies.

Online Trading Operations

Research also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with numerous of users, populated with images of slimming results, positive reviews and step-by-step instructions for mixing or injecting at home.

Within moments of entering one community, a vendor shared contact information, where the majority of transactions take place. The vendor provided an guidebook and promised shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about body mass, medical conditions or past usage.

Product Details and Costs

Within these groups, posts show black plastic packages with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service stated it regularly monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they cannot confirm. Although the research behind this drug is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has already encountered patients injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to possibly serious health risks”.